THR-ARG-SER-ALA-TRP

CAS138949-73-2

THR-ARG-SER-ALA-TRP (CAS 138949-73-2, C27H41 N9 O8) is supplied by ChemSigma for research and manufacturing, with specification, analytical methods and batch documentation available on request.

Chemical structure of THR-ARG-SER-ALA-TRP
C27H41 N9 O8 · 619.67 g/mol
CAS No.
138949-73-2
Formula
C27H41 N9 O8
Mol. weight
619.67 g/mol

Chemical Specifications

Identifiers

CAS number 138949-73-2
Product name THR-ARG-SER-ALA-TRP
Chinese name 人体甲状腺激素相关肽
Synonyms HYPERCALCEMIA OF MALIGNANCY FACTOR (107-111) (HUMAN, BOVINE, DOG, HORSE, MOUSE, RABBIT, RAT)
Chinese synonyms 人体甲状腺激素相关肽; LYS-HIS-LEU-ASN-SER-MET-GLU-ARG-VAL-GLU-TRP-LEU-ARG-LYS-LYS-LEU-GLN-ASP-VAL-HIS-ASN-PHE: KHLNSMERVEWLRKKLQDVHNF
Molecular formula C27H41 N9 O8
Molecular weight 619.67 g/mol

Packaging, Storage & Transport

Available pack sizes 5kg, 1kg, 500g, 100g, 50g, 10g

Read the current safety data sheet before handling. Packaging can be adapted to the order quantity and destination.

Frequently Asked Questions

What is the CAS number of THR-ARG-SER-ALA-TRP?

The CAS Registry Number of THR-ARG-SER-ALA-TRP is 138949-73-2. THR-ARG-SER-ALA-TRP is also known as HYPERCALCEMIA OF MALIGNANCY FACTOR (107-111) (HUMAN, BOVINE, DOG, HORSE, MOUSE, RABBIT, RAT).

What is the molecular formula and molecular weight of THR-ARG-SER-ALA-TRP?

The molecular formula of THR-ARG-SER-ALA-TRP is C27H41 N9 O8, and its molecular weight is 619.67 g/mol.

How can I request a quotation for THR-ARG-SER-ALA-TRP?

Send an inquiry for THR-ARG-SER-ALA-TRP (CAS 138949-73-2) with the required quantity, target specification, destination country and any documentation requirements. ChemSigma will confirm availability, packaging, lead time and price.

Request a Quote for THR-ARG-SER-ALA-TRP

Tell us the required quantity, target specification, destination country and any documentation requirements. We will confirm availability, packaging, lead time and price.

Need custom synthesis or scale-up? Our group company CKS Technology offers custom synthesis, process development and scale-up.